Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 8/2001

01-10-2001

Diagnostic radiation and the risk of multiple myeloma (United States)

Authors: Juliet L. Hatcher, Dalsu Baris, Andrew F. Olshan, Peter D. Inskip, David A. Savitz, G. Marie Swanson, Linda M. Pottern, Raymond S. Greenberg, Ann G. Schwartz, Janet B. Schoenberg, Linda Morris Brown

Published in: Cancer Causes & Control | Issue 8/2001

Login to get access
Metadata
Title
Diagnostic radiation and the risk of multiple myeloma (United States)
Authors
Juliet L. Hatcher
Dalsu Baris
Andrew F. Olshan
Peter D. Inskip
David A. Savitz
G. Marie Swanson
Linda M. Pottern
Raymond S. Greenberg
Ann G. Schwartz
Janet B. Schoenberg
Linda Morris Brown
Publication date
01-10-2001
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 8/2001
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1011205908596

Other articles of this Issue 8/2001

Cancer Causes & Control 8/2001 Go to the issue

OriginalPaper

Socioeconomic status and breast cancer incidence in California for different race/ethnic groups

OriginalPaper

Cigarette smoking and risk of epithelial ovarian cancer (Australia)

OriginalPaper

Primary brain tumors following traumatic brain injury – a population-based cohort study in Sweden

OriginalPaper

Family history and risk of breast cancer in Hispanic and non-Hispanic women: the New Mexico Women's Health Study

OriginalPaper

A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States)

OriginalPaper

Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits